New R package advances multi-pathway cell death analysis

Announcing a new article publication in BIO Integration. The authors of this article developed CellDeathAnalysis (v0.4.0), an R package providing a unified framework for analyzing 14 cell death pathways in bulk RNA-seq data. The package introduces two novel algorithms: Crosstalk-Aware Pathway Scoring, which uses gene specificity weighting (inverse document frequency-inspired) and residual debiasing to reduce redundancy from inter-pathway gene overlap; and Cell Death Subtype Classification, which uses consensus clustering on pathway score profiles to identify biologically meaningful patient subtypes. The package integrates curated gene sets from FerrDb, MSigDB, KEGG, and the primary literature, and implements multiple scoring methods (z-score, ssGSEA, GSVA, and AUCell, and the novel crosstalk-aware method), survival analysis, enrichment analysis, and publication-ready visualizations.

By applying CellDeathAnalysis to 2704 The Cancer Genome Atlas (TCGA) samples across four cancer types (BRCA, LUAD, LIHC, and STAD), the crosstalk-aware method reduced inter-pathway correlation (mean reduction = 0.69) compared to z-score scoring. The disulfidptosis score in LUAD exhibited a significant survival association (HR = 2.19, P_adj = 0.037). Consensus clustering identified clinically meaningful subtypes in LIHC (P = 0.017) and STAD (P = 0.028).

CellDeathAnalysis provides the first dedicated toolkit for multi-pathway cell death analysis with novel crosstalk-aware scoring and subtype classification capabilities. The package addresses the critical challenge of gene overlap between cell death pathways and enables discovery of clinically meaningful patient subtypes.

Source:
Journal reference:

Keran Sun, Keqi Jia and Yunze Niu et al. Cell Death Analysis: A Comprehensive R Package for Multi-pathway Cell Death Analysis in Transcriptomic Data. BIOI. DOI: 10.15212/bioi-2026-004. https://www.scienceopen.com/hosted-document?doi=10.15212/bioi-2026-0046

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New analysis reveals biological features of treatment-resistant aggressive lymphoma